Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Inventory Average of $5.8 million for Q1 2026, up 27.5% sequentially from $4.6 million in Q4 2025, and up 44.21% YoY from $4.0 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Inventory Average for 16 years, with the latest figure at $5.8 million in Q1 2026.
- Quarterly Inventory Average rose 44.21% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 44.21% YoY) and the FY2025 annual result came in at $5.1 million, up 18.77% from the prior year.
- Inventory Average advanced to $5.8 million in Q1 2026 per CPIX's latest filing, from $4.6 million in the prior quarter.
- Over five years, Inventory Average peaked at $10.6 million in Q2 2023 and troughed at $3.1 million in Q3 2025.
- A 5-year average of $6.8 million and a median of $5.8 million in 2026 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2026: Inventory Average plunged 59.12% in 2024, then jumped 44.21% in 2026.
- Over 5 years, Inventory Average stood at $10.3 million in 2022, then tumbled by 35.26% to $6.6 million in 2023, then plunged by 35.92% to $4.3 million in 2024, then gained by 7.65% to $4.6 million in 2025, then climbed by 27.5% to $5.8 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $5.8 million, $4.6 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | 2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Mn |
| Mar 31, 2026 | 5.84 Mn |
| Dec 31, 2025 | 4.58 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.66 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 9.80 Mn |
| Jun 30, 2023 | 10.55 Mn |
| Mar 31, 2023 | 10.02 Mn |
| Dec 31, 2022 | 10.26 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 9.15 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 10.18 Mn |